Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 93.99%4.16B | ---- | 459.16%2.14B | ---- | 135.72%383.23M | ---- | 93.78%-1.07B | ---- | -1,673.49%-17.23B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -0.59%-1.96B | ---- | -125.51%-1.95B | ---- | -88.88%-864.27M | ---- | -206.85%-457.57M | ---- | -369.17%-149.12M |
| Attributable subsidiary (profit) loss | ---- | 20.87%85.53M | ---- | -26.87%70.76M | ---- | 2.75%96.76M | ---- | 22.25%94.17M | ---- | --77.02M |
| Impairment and provisions: | ---- | -61.05%57.36M | ---- | -67.60%147.28M | ---- | 2,803.36%454.58M | ---- | -80.92%15.66M | ---- | 2,790.14%82.08M |
| -Impairmen of inventory (reversal) | ---- | -433.90%-258.49M | ---- | -78.28%77.42M | ---- | 1,670.29%356.38M | ---- | -127.69%-22.7M | ---- | 8,255.05%81.96M |
| -Other impairments and provisions | ---- | 352.13%315.85M | ---- | -28.86%69.86M | ---- | 156.05%98.2M | ---- | 32,679.49%38.35M | ---- | -93.71%117K |
| Revaluation surplus: | ---- | -2,218.48%-1.48B | ---- | -155.00%-64M | ---- | 183.96%116.35M | ---- | -100.79%-138.58M | ---- | 1,284.43%17.49B |
| -Other fair value changes | ---- | -2,218.48%-1.48B | ---- | -155.00%-64M | ---- | 183.96%116.35M | ---- | -100.79%-138.58M | ---- | 1,284.43%17.49B |
| Depreciation and amortization: | ---- | -5.61%214.7M | ---- | 61.69%227.46M | ---- | 122.70%140.68M | ---- | 132.06%63.17M | ---- | 266.71%27.22M |
| -Depreciation | ---- | -5.61%214.7M | ---- | 61.69%227.46M | ---- | 122.70%140.68M | ---- | 132.06%63.17M | ---- | 266.71%27.22M |
| Financial expense | ---- | -13.61%8.19M | ---- | 4.24%9.49M | ---- | 51.68%9.1M | ---- | 75.61%6M | ---- | -90.38%3.42M |
| Exchange Loss (gain) | ---- | -180.99%-12.86M | ---- | 126.06%15.88M | ---- | -106.56%-60.92M | ---- | -461.01%-29.49M | ---- | --8.17M |
| Special items | ---- | -26.23%1.77B | ---- | -0.77%2.4B | ---- | -12.15%2.42B | ---- | 406.59%2.75B | ---- | 186.07%543.06M |
| Operating profit before the change of operating capital | ---- | -5.47%2.83B | ---- | 11.39%3B | ---- | 118.61%2.69B | ---- | 46.00%1.23B | ---- | 70.37%843.52M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -166.11%-523.37M | ---- | 125.12%791.61M | ---- | -145.02%-3.15B | ---- | -146.29%-1.29B | ---- | -218.37%-522.21M |
| Accounts receivable (increase)decrease | ---- | -139.60%-212.71M | ---- | 178.41%537.14M | ---- | -106.72%-685.08M | ---- | -595.36%-331.4M | ---- | -1,310.45%-47.66M |
| Accounts payable increase (decrease) | ---- | 219.64%1.03B | ---- | -112.14%-860.82M | ---- | 121.60%7.09B | ---- | 7.00%3.2B | ---- | 871.41%2.99B |
| prepayments (increase)decrease | ---- | -86.22%98.64M | ---- | 151.59%715.81M | ---- | -709.06%-1.39B | ---- | -43.39%227.8M | ---- | 351.36%402.37M |
| Special items for working capital changes | ---- | 113.65%132.31M | ---- | -198.96%-969.35M | ---- | 353.60%979.54M | ---- | 135.30%215.95M | ---- | 94.57%91.78M |
| Cash from business operations | 235.78%5.71B | 4.55%3.36B | 583.97%1.7B | -42.01%3.21B | -89.06%248.64M | 70.05%5.54B | 16.55%2.27B | -13.31%3.26B | 325.04%1.95B | 619.16%3.76B |
| Other taxs | 35.75%-248.56M | -27.71%-634.59M | -10.41%-386.85M | -224.76%-496.91M | -218.73%-350.38M | 38.79%-153.01M | 37.99%-109.93M | -42.96%-249.98M | -45.00%-177.27M | -27.31%-174.86M |
| Interest received - operating | -14.57%782.88M | -14.88%1.61B | 95.05%916.39M | 265.50%1.89B | 407.48%469.82M | 22.45%516.65M | -42.33%92.58M | 266.90%421.92M | 598.29%160.54M | 377.59%115M |
| Net cash from operations | 180.01%6.24B | -5.92%4.33B | 505.89%2.23B | -22.02%4.6B | -83.69%368.08M | 72.13%5.91B | 16.66%2.26B | -7.26%3.43B | 437.69%1.93B | 803.48%3.7B |
| Cash flow from investment activities | ||||||||||
| Restricted cash (increase) decrease | -1,081.61%-84.15M | -198.05%-17.28M | -133.31%-7.12M | 330.36%17.63M | 92.18%21.38M | -157.75%-7.65M | -13.78%11.12M | 140.51%13.25M | 494.80%12.9M | -1,513.67%-32.71M |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---227.45M |
| Decrease in deposits (increase) | 172.89%4.17B | -17.64%2.82B | -54.09%-5.72B | 567.19%3.43B | -4,396.21%-3.72B | 95.77%-733.51M | 100.63%86.48M | -227.19%-17.35B | -876.88%-13.69B | -274.97%-5.3B |
| Purchase of fixed assets | -174.41%-36.12M | 36.91%-38.6M | 66.67%-13.16M | -52.35%-61.18M | -84.75%-39.49M | 92.00%-40.16M | 5.83%-21.38M | -3,099.00%-502.21M | -241.85%-22.7M | -202.72%-15.7M |
| Purchase of intangible assets | ---- | 4.82%-7.76M | ---- | 99.63%-8.15M | 56.93%-786K | -13,882.88%-2.23B | 61.71%-1.83M | 30.91%-15.95M | -443.44%-4.77M | -4,490.26%-23.09M |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---3.5M |
| Recovery of cash from investments | 166.42%9.16B | 131.50%6.45B | 243.94%3.44B | -41.30%2.79B | 39.85%1B | 25.74%4.75B | -71.76%715.06M | -1.55%3.78B | --2.53B | --3.84B |
| Cash on investment | -176.44%-16.77B | 57.23%-6.07B | -34.65%-6.07B | -137.48%-14.19B | -25.16%-4.51B | -62.55%-5.97B | 6.49%-3.6B | 39.68%-3.68B | -129.04%-3.85B | -22,679.24%-6.09B |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --18.43M |
| Net cash from investment operations | 57.52%-3.56B | 139.22%3.15B | -15.64%-8.37B | -89.42%-8.02B | -157.61%-7.24B | 76.14%-4.24B | 81.30%-2.81B | -126.36%-17.75B | -385.21%-15.03B | -441.38%-7.84B |
| Net cash before financing | 143.77%2.69B | 318.80%7.48B | 10.61%-6.14B | -304.73%-3.42B | -1,139.51%-6.87B | 111.66%1.67B | 95.77%-554.42M | -245.67%-14.32B | -378.32%-13.09B | -298.70%-4.14B |
| Cash flow from financing activities | ||||||||||
| Refund | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---5M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 2.73%6.48B |
| Interest paid - financing | -3.66%-4.17M | 13.61%-8.19M | 8.34%-4.02M | -7.18%-9.49M | 5.15%-4.39M | -80.17%-8.85M | -107.87%-4.63M | -101.06%-4.91M | -224.34%-2.23M | -905.35%-2.44M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | 92.05%-69.1M | ---- | -587.49%-869.04M | ---607.84M | ---126.41M | ---- | ---- |
| Other items of the financing business | ---- | ---- | ---- | ---4.78M | ---4.78M | ---- | ---- | ---- | ---- | 12,672.19%25.57B |
| Net cash from financing operations | -38.99%-30.29M | 61.09%-45.61M | -17.67%-21.79M | 87.34%-117.2M | 97.07%-18.52M | -465.49%-925.45M | -2,314.13%-631.51M | -100.51%-163.65M | -102.88%-26.16M | 392.06%32.03B |
| Effect of rate | -271.96%-109.58M | 209.12%158.64M | -142.91%-29.46M | -120.16%-145.38M | -88.59%68.67M | 235.22%721.27M | 452.41%601.66M | 8.04%-533.41M | -363.50%-170.73M | -1,515.44%-580.05M |
| Net Cash | 143.12%2.66B | 310.26%7.43B | 10.54%-6.16B | -575.07%-3.54B | -481.03%-6.89B | 105.14%744.16M | 90.96%-1.19B | -151.94%-14.49B | -617.02%-13.12B | 409.79%27.89B |
| Begining period cash | 50.49%22.63B | -19.66%15.04B | -19.66%15.04B | 8.49%18.72B | 8.49%18.72B | -46.54%17.25B | -46.54%17.25B | 549.93%32.27B | 549.93%32.27B | 30,525.25%4.97B |
| Cash at the end | 184.71%25.18B | 50.49%22.63B | -25.66%8.84B | -19.66%15.04B | -28.63%11.9B | 8.49%18.72B | -12.18%16.67B | -46.54%17.25B | 493.08%18.98B | 549.93%32.27B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.